1982
DOI: 10.7164/antibiotics.35.251
|View full text |Cite
|
Sign up to set email alerts
|

Isolation and characterization of two 16-membered lactones: 20-deoxorosaramicin and 20-deoxo-12,13-desepoxy-12,13-dehydrorosaramicin aglycones, from a mutant strain of Micromonospora rosaria.

Abstract: Rosaramicin (1), a 16-membered ring macrolide antibiotic, was isolated from the culture filtrate of Micromonospora rosaria'). The biosynthesis of rosaramicin was previously investigated3,3) and established the incorporation of radiolabeled acetic, propionic, and butyric acids and L-methionine into rosaramicin. However, we wished to explore the biosynthetic route of rosaramicin using intermediates and idiotrophs. Therefore, mutants blocked in rosaramicin biosynthesis were generated by the treatment of the rosar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1983
1983
2016
2016

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…A further use of mutants has been the elucidation of metabolic pathways. This has been exploited for the biosynthesis of tetracyclines (McCormick, 1965), novobiocin (Kominek, 1972), erythromycin (Martin et al, 1966;Martin & Rosenbrook, 1967), neomycin (Pearce et al, 1978), tylosin , other aminoglycosides (Penzikova & Levitov M, 1970;Takeda et al, 1978;Fujiwara et al, 1980;Kase et al, 1982;Hanssen & Kirby, 1983), rosaramicin (Vaughn et al, 1982), daunorubicin (McGuire et al, 1981, other anthracyclines Yue et al, 1986), actinomycin (Troost & Katz, 1979), carbapenems (Nozaki et al, 1984;Kojima et al, 1988), ansamycins (Kibby et al, 1980;Ghisalba et al, 1981), patulin (Gaucher et al, 1981 and phenazines (Byng et al, 1979).…”
Section: Use Of Mutants To Elucidate Biosynthetic Pathwaysmentioning
confidence: 99%
“…A further use of mutants has been the elucidation of metabolic pathways. This has been exploited for the biosynthesis of tetracyclines (McCormick, 1965), novobiocin (Kominek, 1972), erythromycin (Martin et al, 1966;Martin & Rosenbrook, 1967), neomycin (Pearce et al, 1978), tylosin , other aminoglycosides (Penzikova & Levitov M, 1970;Takeda et al, 1978;Fujiwara et al, 1980;Kase et al, 1982;Hanssen & Kirby, 1983), rosaramicin (Vaughn et al, 1982), daunorubicin (McGuire et al, 1981, other anthracyclines Yue et al, 1986), actinomycin (Troost & Katz, 1979), carbapenems (Nozaki et al, 1984;Kojima et al, 1988), ansamycins (Kibby et al, 1980;Ghisalba et al, 1981), patulin (Gaucher et al, 1981 and phenazines (Byng et al, 1979).…”
Section: Use Of Mutants To Elucidate Biosynthetic Pathwaysmentioning
confidence: 99%